Use of extracorporeal membrane oxygenation in cystic fibrosis in an Australian cystic fibrosis centre
Abstract
Extracorporeal membrane oxygenation (ECMO) support is used in selected patients with cystic fibrosis (CF) as a bridge to transplantation. Our aim was to describe briefly treatment and outcomes of six CF patients who received ECMO. One patient received a lung transplant and another recovered from acute respiratory failure. Four died despite ECMO support. Lack of timely availability of suitable donor lungs and patient selection are contributing factors.
Source: Internal Medicine Journal - Category: Internal Medicine Authors: Sheila Sivam, Ruth Dentice, Nazmeen Reddy, Carmel Moriarty, Veronica Yozghatlian, Craig Mellis, Paul Torzillo, Allan Glanville, David Gattas, Peter Bye Tags: Brief Communications Source Type: research
More News: Australia Health | Cystic Fibrosis | Internal Medicine | Lung Transplant | Respiratory Medicine | Transplant Surgery | Transplants